Nanomaterial-treated tumor cells release mtDNA fragments that are taken up by TAMs, activate the cGAS-STING pathway, and undergo reprogramming, which helps to alleviate immunosuppression in the tumor microenvironment and enhances T-cell-mediated anti-tumor immune responses. This evidence concerns the gene STING1 and neoplasm.